Related Experiment Video

Updated: Apr 29, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Usefulness of Diffusion-Weighted MRI for Differentiation between Parkinson's Disease and Parkinson Variant of

Eun Joo Chung1, Eung Gyu Kim1, Jong Seok Bae1

  • 1Departments of Neurology, Inje University College of Medicine, Busan, Korea.

Journal of Movement Disorders
|May 29, 2014
PubMed
Abstract

Insights

Diffusion-weighted imaging (DWI) effectively distinguishes Parkinson variant of multiple system atrophy (MSA-p) from Parkinson's disease (PD) using regional apparent diffusion coefficient (rADC) values. The middle cerebellar peduncle (MCP) rADC offers superior diagnostic accuracy for differentiating MSA-p from PD.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Parkinsonian symptoms can arise from Parkinson's disease (PD) or Parkinson variant of multiple system atrophy (MSA-p).
  • Accurate differential diagnosis is crucial for appropriate patient management and treatment.
  • Diffusion-weighted imaging (DWI) shows potential in differentiating these conditions.

Purpose of the Study:

  • To evaluate the diagnostic utility of DWI, specifically the regional apparent diffusion coefficient (rADC), in distinguishing MSA-p from PD.
  • To investigate the correlation between rADC values and clinical features in both MSA-p and PD patients.

Main Methods:

  • A cohort of 12 PD patients and 10 MSA-p patients were included in the study.
  • rADC values were measured in specific brain regions: dorsal putamen (DP) and middle cerebellar peduncles (MCP).
  • Statistical analysis was performed to compare rADC values between groups and assess correlations with clinical data.

Main Results:

  • Significantly higher rADC values were observed in the DP and MCP of MSA-p patients compared to PD patients (p=0.03 for DP, p=0.0001 for MCP).
  • The MCP rADC demonstrated higher sensitivity, specificity, and positive predictive value for differentiating MSA-p from PD than the DP rADC.
  • No significant correlation was found between rADC values in the DP or MCP and the clinical features of either MSA-p or PD.

Conclusions:

  • DWI, utilizing rADC values in the DP and MCP, can effectively discriminate between MSA-p and PD.
  • The rADC measurement in the MCP is particularly valuable for enhancing diagnostic accuracy in differentiating MSA-p from PD.
Keywords:
Diffusion-weighted imagingMultiple system atrophyParkinson’s disease

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.9K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
21
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.6K